Wednesday, August 01, 2012 9:09:43 AM
Recent CEL News
- Celadon hails early results of chronic pain trial • Alliance News • 03/08/2024 08:04:45 PM
- Celadon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study Data • RNS Non-Regulatory • 03/07/2024 07:00:13 AM
- Celadon announces start of cannabis supply for two UK companies • Alliance News • 12/14/2023 02:18:53 PM
- Celadon Pharmaceuticals PLC Product Supplied to First Two Sales Contracts • UK Regulatory • 12/14/2023 07:00:00 AM
- Celadon Pharma raises GBP2.0 million via placing • Alliance News • 12/12/2023 05:40:04 PM
- Celadon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVR • UK Regulatory • 12/12/2023 02:00:00 PM
- Celadon shares rise on supply contract worth up to GBP26 million • Alliance News • 11/16/2023 11:45:35 AM
- Celadon Pharmaceuticals PLC New European Sales Contract • UK Regulatory • 11/16/2023 07:00:00 AM
- Celadon Pharmaceuticals raises GBP1.0 million through shares • Alliance News • 10/13/2023 02:42:26 PM
- Celadon Pharmaceuticals PLC Fundraise, CLN Issue, Joint Broker Appointed & TVR • UK Regulatory • 10/13/2023 06:00:00 AM
- Celadon Pharmaceuticals interim loss narrows; optimistic for future • Alliance News • 09/28/2023 11:14:47 AM
- Celadon Pharmaceuticals PLC Interim Results • UK Regulatory • 09/28/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 09/18/2023 06:00:00 AM
- Celadon shares rise on second UK contract win for cannabis product • Alliance News • 09/05/2023 09:48:42 AM
- Celadon Pharmaceuticals PLC New Sales Contract with UK Pharmaceutical Company • UK Regulatory • 09/05/2023 06:00:00 AM
- Celadon receives approval for 5,000 patient clinical cannabis trial • Alliance News • 08/01/2023 10:44:46 AM
- Celadon Pharmaceuticals PLC Approval to roll-out chronic pain clinical trial • UK Regulatory • 08/01/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Result of AGM • UK Regulatory • 06/29/2023 04:30:00 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report and Notice of AGM • UK Regulatory • 06/05/2023 01:46:00 PM
- Celadon Pharmaceuticals loss widens; confident amid three-year deal • Alliance News • 06/05/2023 11:23:05 AM
- Celadon Pharmaceuticals PLC Final Results for the year ended 31 December 2022 • UK Regulatory • 06/05/2023 06:00:00 AM
- Celadon secures GBP7 million credit facility as product demand grows • Alliance News • 05/30/2023 10:56:00 AM
- Celadon Pharmaceuticals PLC GBP7 Million Committed Credit Facility • UK Regulatory • 05/30/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 05/26/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC West Midlands Mayor Visits Celadon's Facility • RNS Non-Regulatory • 05/25/2023 06:00:00 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM